Taking people in United StatesPhase 2
Tests a travoprost eye implant in adults with glaucoma
Tests a second-generation travoprost implant in adults with glaucoma.
Plain-language title generated from the registry record
Registry title: Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Key facts
- Where
- El Paso, Grand Junction, and Oklahoma City, United StatesSee the 3 sites
- Phase
- Phase 2
Where in United States
- El PasoEl Paso, United StatesTaking people
- Grand JunctionGrand Junction, United StatesTaking people
- Oklahoma CityOklahoma City, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Glaukos Corporation
- Trial code
- NCT07075718
- Record updated
- 17 September 2026
- Original description
Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral ImplantRead full original descriptionShow less
Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Inclusion: Diagnosis of open-angle glaucoma or ocular hypertension in the study eye.
Exclusion: Prior incisional glaucoma surgery in the study eye; Prior minimally invasive glaucoma (MIGS) surgery in the study eye; Prior argon laser trabeculoplasty (ALT) in the study eye.